NEW YORK, Dec. 10, 2025 /PRNewswire/ -- MidCap Advisors, a leading lower-middle-market investment bank specializing in mergers and acquisitions, is pleased to announce its role as exclusive financial ...
Hosted on MSN
Weight-loss drug Mounjaro reverses health benefits when you stop taking it, study finds
New research shows stopping Mounjaro causes rapid weight regain and reverses health improvements like lower blood pressure and cholesterol levels. Alarm grows in Europe over what is seen as Trump's ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...
You can trust VideoGamer. Our team of gaming experts spend hours testing and reviewing the latest games, to ensure you're reading the most comprehensive guide possible. Rest assured, all imagery and ...
Although millions of Americans use cannabis for medical reasons, new research suggests that there is not enough evidence to support much of that medicinal use. The research, published in the Journal ...
Waseem is a writer here at GameRant. He can still feel the pain of Harry Du Bois in Disco Elysium, the confusion of Alan Wake in the Remedy Connected Universe, the force of Ken's shoryukens and the ...
In New York, early voting began Saturday, Oct. 25 and ended Sunday, Nov. 2. You can vote early by mail in New York. You must request a mail-in ballot from the state election board and return it before ...
IVI RMA, the world’s leading reproductive medicine group, announced that joint research with Juno Genetics that utilized data from the Foundation for Embryonic Competence and RMA New Jersey won the ...
GENEVA, Oct 22 (Reuters) - Leading AI assistants misrepresent news content in nearly half their responses, according to new research published on Wednesday by the European Broadcasting Union (EBU) and ...
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Multitude Therapeutics, Inc., a clinical stage biopharmaceutical company focused on the development of ADC drugs, today announced interim results from its ...
Promising antitumor activity was observed in heavily pretreated patients with melanoma and gynecologic cancers without MUC18 preselection SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Multitude Therapeutics ...
Promising efficacies were observed in patients with heavily pretreated EGFR Wild-type NSCLC and other advanced solid tumors without CD44v9 pre-selection SHANGHAI, Oct. 17, 2025 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback